help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2006-0514
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gururaj, A. E.
Right arrow Articles by Kumar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gururaj, A. E.
Right arrow Articles by Kumar, R.
Molecular Endocrinology 21 (8): 1847-1860
Copyright © 2007 by The Endocrine Society

Estrogen Induces Expression of BCAS3, a Novel Estrogen Receptor-{alpha} Coactivator, through Proline-, Glutamic Acid-, and Leucine-Rich Protein-1 (PELP1)

Anupama E. Gururaj, Shaohua Peng, Ratna K. Vadlamudi and Rakesh Kumar

Molecular and Cellular Oncology (A.E.G., S.P., R.K.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Obstetrics and Gynecology (R.K.V.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; and Molecular and Cellular Biology (R.K.), Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: Rakesh Kumar, Molecular and Cellular Oncology, Unit 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030. E-mail: rkumar{at}mdanderson.org.

We recently reported that the breast carcinoma amplified sequence-3 (BCAS3) gene is regulated by estrogen receptor (ER) {alpha}. However, the role of ER{alpha} coactivators in the regulation of BCAS3 expression remains unknown, and information regarding the function of the BCAS3 protein is lacking. Here, we define the contribution of ER{alpha} coactivators to BCAS3 regulation and identify BCAS3 itself as an ER{alpha} coactivator in breast cancer cells. We found that PELP1 (proline-, glutamic acid-, and leucine-rich protein-1), a newly described ER{alpha} coregulator, is recruited to BCAS3 chromatin and activates its expression. Analysis of the BCAS3 sequence for functional motifs and evidence from biochemical fractionation suggested that BCAS3 acts as a transcriptional coactivator. Results from chromatin immunoprecipitation, reporter assays, and expression studies further validated the coactivator function of BCAS3 for ER{alpha}. BCAS3 physically associated with histone H3 and histone acetyltransferase complex protein P/CAF (p300/CBP-associated factor) and possessed histone acetyltransferase activity. Unexpectedly, BCAS3 required PELP1 to function as a coactivator in ER{alpha} transactivation activity. In brief, these results highlight a mechanism whereby ER{alpha} activation triggers a positive feedback loop leading to signal amplification in the cell.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα
Coregulators:   P/CAF  |  CBP  |  SRC-1  |  PELP1  |  GRIP1  |  AIB1
Ligands:   17β-Estradiol  |  Fulvestrant






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society